About us
Chronic Myeloid Leukaemia Europe informs European healthcare professionals around Incyte’s commitment to the treatment of patients with chronic myeloid leukaemia (CML). CML is one of the most common forms of leukaemia in adults and is divided into 3 stages: chronic phase, accelerated phase and blast phase.* View our social guidelines here: http://bit.ly/2sV0H5W *Rinaldi I. Winston K. J Blood Med. 2023;14:261–77.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees